Alphatec Adds Industry Experience
26 Octobre 2006 - 5:30PM
PR Newswire (US)
CARLSBAD, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Alphatec
Holdings, Inc. (NASDAQ:ATEC), a spinal device company, announced
today that M. Ross Simmonds has joined the Company as Senior Vice
President, Sales and Marketing. In this position, Mr. Simmonds will
provide leadership in sales and marketing and report directly to
Ronald G. Hiscock, President and Chief Executive Officer. "We are
delighted to have Ross as a member of the executive team with his
30 year track record of implementing sales and marketing plans,
launching new products and building long-term relationships in the
spine industry," said John H. Foster, Executive Chairman. "We are
confident that under his leadership Alphatec will achieve
sustainable sales growth and maintain its leading position in the
market." Mr. Simmonds is an experienced executive and spine
industry expert. Mr. Simmonds was previously the Chief Operating
Officer and Senior Vice President at Long Beach Memorial Medical
Center and Miller Children's Hospital in Long Beach, California,
responsible for a $1.7 billion operation. From 1989 to 2004, Mr.
Simmonds held world wide senior level sales, marketing and
distribution development positions at Interpore Cross
International, a company that designs, manufactures and markets
synthetic bone and tissue products and spinal implant devices. In
his most recent position at Interpore, Mr. Simmonds served as
Corporate Officer, responsible for strategic sales and marketing
planning and selling strategies for various orthopedic products,
including spinal implants. Earlier in his career, Mr. Simmonds held
various managerial positions in the sales and marketing of
orthopedic implants and instruments. Mr. Simmonds received a
Bachelors of Science from Louisiana State University. "It is with
great enthusiasm that I am joining Alphatec," commented Mr.
Simmonds, "with its high growth, capable management, an extensive
growing portfolio of spinal products and an exceptional world-class
manufacturing facility." "Also, we are delighted to announce the
election of Stephen H. Hochschuler, M.D. to our Board of
Directors," said Mr. Foster. "As Chairman of our Scientific
Advisory Board, he has provided us with invaluable technical
advice. In his expanded role as a Director, I am confident that
Stephen's countless relationships within the spinal community will
significantly enhance the Company. Dr. Hochschuler is a Co-Founder
of the Texas Back Institute and a Founding Member of the Board of
Directors of the Spine Arthroplasty Society. He is currently the
President of the Society. He has held several top committee
positions in the North American Spine Society. Additionally, Dr.
Hochschuler is a member of the American Academy of Orthopedic
Surgeons, one of the Founders of The American Board of Spine
Surgery. He has lectured at more than 200 spine-related medical
meetings throughout his career. His surgical practice is conducted
in Plano, Texas and Phoenix, Arizona. Dr. Hochschuler currently
serves on the Scientific and Business Advisory Boards of several
spinal device companies. "I am honored to join Alphatec's Board of
Directors and be part of such an accomplished and experienced
team," said Dr. Hochschuler. "Despite past inquiries I have not
accepted previous invitations to join company's Boards of
Directors. I am particularly enthusiastic about the Alphatec team
and platform." About Alphatec Alphatec is a medical device company
focused on the design, development, manufacturing and marketing of
products for the surgical treatment of spine disorders. Alphatec's
principal product offerings are primarily focused on the U.S. spine
fusion market, which is estimated to approach $3 billion in 2007,
through its wholly-owned subsidiary, Alphatec Spine, Inc., and
include a variety of spinal implant products and systems comprised
of components such as spine screws, spinal spacers, and plates that
offer multiple solutions to address patients' needs. In addition to
Alphatec's U.S. presence, it also participates in the Japanese
spine fusion and orthopedic trauma markets through its subsidiary,
Alphatec Pacific, Inc. Our mission is to be a values based leader
in the spinal device market by providing unmatched service to and
taking scientific direction from our surgeon customers. We do so
through our unique in-house manufacturing facility in Carlsbad,
California that allows us to respond quickly to surgeon needs and
to customize innovative products needed for spine fusion surgery.
Forward Looking Statements This press release may contain
forward-looking statements that involve risks and uncertainty. Such
statements are based on management's current expectations and are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the
forward- looking statements. Alphatec cautions investors that there
can be no assurance that actual results or business conditions will
not differ materially from those projected or suggested in such
forward-looking statements as a result of various factors,
including, but not limited to, the following: Alphatec's ability to
maintain its level of previously reported sales growth, Alphatec's
ability to develop and expand its spine fusion business in the
United States and Japan, Alphatec's ability to expand and maintain
a successful sales and marketing organization, continuation of
favorable third party payor reimbursement for procedures performed
using our products, unanticipated expenses or liabilities or other
adverse events affecting cash flow or Alphatec's ability to achieve
profitability, uncertainty of additional funding, uncertainty of
success in developing any new products, failure to successfully
introduce and develop new products, including products related to
license agreements, failure to obtain FDA clearance or approval for
particular devices, Alphatec's ability to compete with other
competing products and with emerging new technologies within and
outside of spinal fusion, product liability exposure, patent
infringement claims and claims related to our intellectual
property. Please refer to the risks detailed in Alphatec's Form S-1
on file with the SEC, as well as the risks detailed from time to
time in Alphatec's SEC reports, including quarterly reports on Form
10-Q, reports on Form 8-K and annual reports on Form 10-K. We
disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise, unless required by law. Contacts:
Alphatec Holdings, Inc. Steven Yasbek 760.431.9286 x403 Noonan
Russo Brian Ritchie 212.845.4269 DATASOURCE: Alphatec Holdings,
Inc. CONTACT: Steven Yasbek, Alphatec Holdings, Inc.,
+1-760-431-9286 ext. 403, ; or Brian Ritchie, Noonan Russo,
+1-212-845- 4269,
Copyright
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Août 2023 à Août 2024